Polar Light Ventures
Providing investment to early-stage companies backed by strong entrepreneurs
Polar Light Ventures
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
We actively support our founders
and portfolio companies to
achieve their goals by
leveraging our extensive
global network
What’s new in our portfolio
Skin Analytics wins NHSX award for AI skin cancer tool
LONDON, June 18, 2021 (Healthcare Global) — An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care’s initiative to bring technology into the UK’s national health system…
First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial in Oncology
SAN DIEGO, Nov. 17, 2021 (GLOBAL NEWSWIRE) — Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major diseases, announced the dosing of the first subject in a Phase 1b, open-label, multi-center, dose-escalation, dose expansion clinical trial of cirtuvivint in subjects with advanced solid tumors…
Maximon launches 100 million Longevity Co-Investment Fund
Zug, October 7, 2021 (Longevity Technology) — The Longevity Co-Investment Fund finances longevity focussed start-up companies launched by company builder Maximon…
eCurrency announces new investor joining their funding round
DUBLIN, October 5, 2021 (The Paypers) — eCurrency Mint has closed a funding round with new investors including Pandit, the former CEO of Citi Group, according to discussions we had with company representatives…